Every year the FTC brings hundreds of cases against individuals and companies for violating consumer protection and competition laws that the agency enforces. These cases can involve fraud, scams, identity theft, false advertising, privacy violations, anti-competitive behavior and more. The Legal Library has detailed information about cases we have brought in federal court or through our internal administrative process, called an adjudicative proceeding.
Actavis, Inc. and Warner Chilcott PLC, In the Matter of
Under a settlement, the FTC required Watson Pharmaceuticals, Inc. and Actavis Inc. to sell the rights and assets to 18 drugs to Sandoz International GmbH and Par Pharmaceuticals, Inc, and relinquish the manufacturing and marketing rights to three others, to settle charges that Watson’s proposed $5.9 billion acquisition of Actavis would otherwise be anticompetitive.The settlement protects competition in the markets for 21 current and future generic drugs, used to treat a wide range of conditions ranging from hypertension and diabetes to anxiety and attention deficit hyperactivity disorder (ADHD).
E.K. Ekcessories, Inc., In the Matter of
Grant Connect, LLC; Global Gold, Inc., et al.
Statement of Chairwoman Edith Ramirez on “The FTC at 100”
Statement of Commissioner Joshua D. Wright - The FTC at 100: Where Do We Go From Here?
Statement of Commissioner Julie Brill on The FTC at 100: Where Do We Go from Here?
Loewen, Matthew J., d/b/a Vehicle Stars; 0803065 B.C. Ltd., d/b/a Auto Marketing Group
Honeywell International Inc., In the Matter of
Honeywell International Inc agreed to license patents critical to the manufacture of two-dimensional (2D) bar code scanners to settle FTC charges that it's acquisition of rival Intermed Inc would be anticompetitive. Honeywell will license its and Intermec's patents for 2D scan engines to Datalogic IPTECH s.r.l for the next 12 years.